|
Market Closed -
Nasdaq
01:30:00 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.590 USD | -1.24% |
|
+1.80% | -8.67% |
| 16/07 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 01/06 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
IMTX 9.590 $
-1.24%
25.46L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| IMTX | 9.590USD | -1.24% | 25.46L $ | |
CBOE
| IMTX | 9.595USD | -1.18% | 87.4T $ | |
|
Deutsche Boerse AG
| 4A3 | 8.265EUR | -3.33% | 13.8T € | |
|
Börse Stuttgart
| 4A3 | 8.260EUR | -1.14% | 10.47T € | |
|
Tradegate
| 4A3 | 8.330EUR | -1.19% | 1.71T € | |
|
Boerse Muenchen
| 4A3 | 8.370EUR | -0.95% | 284.58 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bullish |
| Resistance | 10.26 | 10.26 | 11.62 |
| Spread/Res. | -6.53% | -6.53% | -17.47% |
| Spread/Supp. | +11.12% | +11.12% | +15.26% |
| Support | 8.63 | 8.63 | 8.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
